ID
× COMMENTARYEDITOR'S PAGECOVER STORYIN THE NEWSNEWSFRONTSCHEMENTATOR + Show More
Chemical Engineering MagazineChementator Briefs
Forward Osmosis Last month, Bioindustrial Innovation Canada (BIC; Sarnia, Ont.;…
BUSINESS NEWSTECHNICAL & PRACTICALFEATURE REPORTFACTS AT YOUR FINGERTIPSTECHNOLOGY PROFILESOLIDS PROCESSINGENGINEERING PRACTICEEQUIPMENT & SERVICESFOCUSNEW PRODUCTS + Show More

Comment

Wood Group awarded EPCM contract from GlaxoSmithKline for German biotech facility

By Mary Page Bailey |

Wood Group plc (Aberdeen, Scotland; www.woodgroup.com) is providing GSK Vaccines GmbH (GSK), part of GlaxoSmithKline Group, with engineering, procurement and construction management (EPCM) services for a new biotech facility to be built in Marburg, Germany.


The new multi-million dollar contract includes detailed design, procurement and subcontracting services, expediting and inspection of process equipment and packages, construction management, coordination of commissioning, engineering follow-up during construction, design qualification, as well as the overall project management.


Wood’s Environment & Infrastructure Solutions business has already completed outline design for the facility, which will produce bulk recombinant proteins used in meningitis vaccines. Completion of commissioning is scheduled for July 2019.


The contract builds on Wood’s 12-year relationship supporting GSK Vaccines GmbH across its global portfolio and is the second to be awarded under a five-year master agreement, signed in June 2016.


Robin Watson, Wood’s chief executive, said: “This new contract recognises GSK’s confidence in our global capabilities and broad, innovative solutions, based on our strong track record of supporting them for over a decade in locations including Singapore, Belgium, Italy, France and Hungary.


“Our focus is applying our vast knowledge and expertise in designing and constructing vaccines facilities, to ensure the safe and efficient delivery of this significant project in Germany. We look forward to working in partnership with GSK on this contract, which is another significant step towards delivering our growth ambitions in the pharmaceuticals sector.”

Related Content

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
ABB Ability™ technology to transform BASF rotating equipment into intelligent machinery and improve uptime and reliability
Detect and correct anomalies early in your batch processes
ABB at ACHEMA 2018
The Future of Project Execution
Digitalization: What does it deliver today… and tomorrow?

View More

Live chat by BoldChat